Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction - PubMed (original) (raw)
Case Reports
doi: 10.1159/000069805.
Affiliations
- PMID: 12697994
- DOI: 10.1159/000069805
Case Reports
Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction
M Gross et al. Cytogenet Genome Res. 2002.
Abstract
Fanconi anemia (FA) is a genetically and phenotypically heterogenous autosomal recessive disease associated with chromosomal instability and hypersensitivity to DNA crosslinkers. Prognosis is poor due to progressive bone marrow failure and increased risk of neoplasia, but revertant mosaicism may improve survival. Mechanisms of reversion include back mutation, intragenic crossover, gene conversion and compensating deletions/insertions. We describe the types of reversions found in five mosaic FA patients who are compound heterozygotes for single base mutations in FANCA or FANCC. Intragenic crossover could be shown as the mechanism of self-correction in the FANCC patient. Restoration to wildtype via back mutation or gene conversion of either the paternal or maternal allele was observed in the FANCA patients. The sequence environments of these mutations/reversions were indicative of high mutability, and selective advantage of bone marrow precursor cells carrying a completely restored FANCA allele might explain the surprisingly uniform pattern of these reversions. We also describe a first example of in vitro phenotypic reversion via the emergence of a compensating missense mutation 15 amino acids downstream of the constitutional mutation, which explains the reversion to MMC resistance of the respective lymphoblastoid cell line. With one exception, our mosaic patients showed improvement of their hematological status during a three- to six-year observation period, indicating a proliferative advantage of the reverted cell lineages. In patients with Fanconi anemia, genetic instability due to defective caretaker genes sharply increases the risk of neoplasia, but at the same time increases the chance for revertant mosaicism leading to improved bone marrow function.
Copyright 2002 S. Karger AG, Basel
Similar articles
- Fanconi anemia: causes and consequences of genetic instability.
Kalb R, Neveling K, Nanda I, Schindler D, Hoehn H. Kalb R, et al. Genome Dyn. 2006;1:218-242. doi: 10.1159/000092510. Genome Dyn. 2006. PMID: 18724063 Review. - Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance.
Lo Ten Foe JR, Kwee ML, Rooimans MA, Oostra AB, Veerman AJ, van Weel M, Pauli RM, Shahidi NT, Dokal I, Roberts I, Altay C, Gluckman E, Gibson RA, Mathew CG, Arwert F, Joenje H. Lo Ten Foe JR, et al. Eur J Hum Genet. 1997 May-Jun;5(3):137-48. Eur J Hum Genet. 1997. PMID: 9272737 - Spontaneous functional correction of homozygous fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism.
Waisfisz Q, Morgan NV, Savino M, de Winter JP, van Berkel CG, Hoatlin ME, Ianzano L, Gibson RA, Arwert F, Savoia A, Mathew CG, Pronk JC, Joenje H. Waisfisz Q, et al. Nat Genet. 1999 Aug;22(4):379-83. doi: 10.1038/11956. Nat Genet. 1999. PMID: 10431244 - Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei.
Francies FZ, Wainwright R, Poole J, De Leeneer K, Coene I, Wieme G, Poirel HA, Brichard B, Vermeulen S, Vral A, Slabbert J, Claes K, Baeyens A. Francies FZ, et al. DNA Repair (Amst). 2018 Jan;61:17-24. doi: 10.1016/j.dnarep.2017.11.001. Epub 2017 Nov 8. DNA Repair (Amst). 2018. PMID: 29154021 - [Molecular basis of Fanconi's anemia].
Digweed M. Digweed M. Klin Padiatr. 1999 Jul-Aug;211(4):192-7. doi: 10.1055/s-2008-1043786. Klin Padiatr. 1999. PMID: 10472548 Review. German.
Cited by
- Lentivirus-mediated gene therapy corrects ribosomal biogenesis and shows promise for Diamond Blackfan anemia.
Giménez Y, Palacios M, Sánchez-Domínguez R, Zorbas C, Peral J, Puzik A, Ugalde L, Alberquilla O, Villanueva M, Río P, Gálvez E, Da Costa L, Strullu M, Catala A, Ruiz-Llobet A, Segovia JC, Sevilla J, Strahm B, Niemeyer CM, Beléndez C, Leblanc T, Lafontaine DL, Bueren J, Navarro S. Giménez Y, et al. JCI Insight. 2024 May 22;9(10):e171650. doi: 10.1172/jci.insight.171650. JCI Insight. 2024. PMID: 38775150 Free PMC article. - Identification of a robust DNA methylation signature for Fanconi anemia.
Pagliara D, Ciolfi A, Pedace L, Haghshenas S, Ferilli M, Levy MA, Miele E, Nardini C, Cappelletti C, Relator R, Pitisci A, De Vito R, Pizzi S, Kerkhof J, McConkey H, Nazio F, Kant SG, Di Donato M, Agolini E, Matraxia M, Pasini B, Pelle A, Galluccio T, Novelli A, Barakat TS, Andreani M, Rossi F, Mecucci C, Savoia A, Sadikovic B, Locatelli F, Tartaglia M. Pagliara D, et al. Am J Hum Genet. 2023 Nov 2;110(11):1938-1949. doi: 10.1016/j.ajhg.2023.09.014. Epub 2023 Oct 20. Am J Hum Genet. 2023. PMID: 37865086 Free PMC article. - A self-repair history: compensatory effect of a de novo variant on the FANCA c.2778+83C>G splicing mutation.
Persico I, Fontana G, Faleschini M, Zanchetta ME, Ammeti D, Cappelli E, Corsolini F, Mosa C, Guarina A, Bogliolo M, Surrallés J, Dufour C, Farruggia P, Savoia A, Bottega R. Persico I, et al. Front Genet. 2023 Jul 20;14:1209138. doi: 10.3389/fgene.2023.1209138. eCollection 2023. Front Genet. 2023. PMID: 37547463 Free PMC article. - Chromosomal Instability in Genome Evolution: From Cancer to Macroevolution.
Comaills V, Castellano-Pozo M. Comaills V, et al. Biology (Basel). 2023 Apr 28;12(5):671. doi: 10.3390/biology12050671. Biology (Basel). 2023. PMID: 37237485 Free PMC article. Review. - Adenine base editing efficiently restores the function of Fanconi anemia hematopoietic stem and progenitor cells.
Siegner SM, Ugalde L, Clemens A, Garcia-Garcia L, Bueren JA, Rio P, Karasu ME, Corn JE. Siegner SM, et al. Nat Commun. 2022 Nov 12;13(1):6900. doi: 10.1038/s41467-022-34479-z. Nat Commun. 2022. PMID: 36371486 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous